RhumbLine Advisers
LFCR icon

RhumbLine Advisers’s Lifecore Biomedical LFCR Stock Holding History

RhumbLine Advisers’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Sell
32,258
-1,437
-4% -$9.92K ﹤0.01% 3330
2025
Q4 		$276K Sell
33,695
-3,701
-10% -$27.4K ﹤0.01% 3021
2025
Q3 		$275K Sell
37,396
-695
-2% -$5.26K ﹤0.01% 3054
2025
Q2 		$309K Buy
38,091
+13,361
+54% +$90.1K ﹤0.01% 2967
2025
Q1 		$174K Sell
24,730
-30,993
-56% -$193K ﹤0.01% 3177
2024
Q4 		$414K Buy
55,723
+31,056
+126% +$198K ﹤0.01% 2786
2024
Q3 		$122K Sell
24,667
-2,232
-8% -$11.7K ﹤0.01% 3445
2024
Q2 		$138K Buy
26,899
+25,378
+1,669% +$150K ﹤0.01% 3401
2024
Q1 		$8.08K Hold
1,521
– – ﹤0.01% 3905
2023
Q4 		$9.41K Hold
1,521
– – ﹤0.01% 3872
2023
Q3 		$11.5K Sell
1,521
-1,637
-52% -$15K ﹤0.01% 3856
2023
Q2 		$30.5K Sell
3,158
-38,804
-92% -$237K ﹤0.01% 3751
2023
Q1 		$158K Buy
41,962
+647
+2% +$3.61K ﹤0.01% 2788
2022
Q4 		$268K Buy
41,315
+614
+2% +$5.06K ﹤0.01% 2713
2022
Q3 		$362K Buy
40,701
+2,820
+7% +$28.7K ﹤0.01% 2643
2022
Q2 		$378K Buy
37,881
+1,471
+4% +$14.6K ﹤0.01% 2632
2022
Q1 		$422K Sell
36,410
-3,120
-8% -$34.7K ﹤0.01% 2495
2021
Q4 		$439K Sell
39,530
-59
-0.1% -$573 ﹤0.01% 2566
2021
Q3 		$365K Buy
39,589
+756
+2% +$8.23K ﹤0.01% 2686
2021
Q2 		$437K Sell
38,833
-7,056
-15% -$81.3K ﹤0.01% 2624
2021
Q1 		$486K Sell
45,889
-100
-0.2% -$1.12K ﹤0.01% 2512
2020
Q4 		$499K Buy
45,989
+5,437
+13% +$56.2K ﹤0.01% 2442
2020
Q3 		$394K Sell
40,552
-6,152
-13% -$58.6K ﹤0.01% 2398
2020
Q2 		$372K Buy
46,704
+3,576
+8% +$36.9K ﹤0.01% 2464
2020
Q1 		$375K Buy
43,128
+1,643
+4% +$17.1K ﹤0.01% 2293
2019
Q4 		$469K Buy
41,485
+82
+0.2% +$873 ﹤0.01% 2390
2019
Q3 		$450K Buy
41,403
+3,146
+8% +$34.2K ﹤0.01% 2375
2019
Q2 		$358K Sell
38,257
-1,050
-3% -$10.6K ﹤0.01% 2513
2019
Q1 		$483K Buy
39,307
+884
+2% +$10.8K ﹤0.01% 2341
2018
Q4 		$455K Buy
38,423
+11,792
+44% +$162K ﹤0.01% 2338
2018
Q3 		$383K Hold
26,631
– – ﹤0.01% 2386
2018
Q2 		$397K Buy
26,631
+1,035
+4% +$14.4K ﹤0.01% 2407
2018
Q1 		$334K Sell
25,596
-1,225
-5% -$16.1K ﹤0.01% 2387
2017
Q4 		$338K Sell
26,821
-4,801
-15% -$60.7K ﹤0.01% 2404
2017
Q3 		$410K Buy
31,622
+245
+0.8% +$3.23K ﹤0.01% 2409
2017
Q2 		$466K Sell
31,377
-7,238
-19% -$101K ﹤0.01% 2342
2017
Q1 		$463K Buy
38,615
+5,660
+17% +$71.7K ﹤0.01% 2283
2016
Q4 		$455K Sell
32,955
-3,217
-9% -$44.6K ﹤0.01% 2278
2016
Q3 		$485K Buy
36,172
+240
+0.7% +$2.91K ﹤0.01% 2225
2016
Q2 		$387K Sell
35,932
-5,993
-14% -$66.1K ﹤0.01% 2371
2016
Q1 		$440K Buy
41,925
+3,300
+9% +$36.2K ﹤0.01% 2301
2015
Q4 		$457K Buy
38,625
+2,755
+8% +$33.8K ﹤0.01% 2300
2015
Q3 		$419K Buy
35,870
+1,793
+5% +$23.8K ﹤0.01% 2349
2015
Q2 		$492K Sell
34,077
-4,525
-12% -$65.3K ﹤0.01% 2342
2015
Q1 		$538K Buy
38,602
+2,000
+5% +$27.6K ﹤0.01% 2263
2014
Q4 		$505K Buy
36,602
+3,200
+10% +$41.3K ﹤0.01% 2269
2014
Q3 		$409K Hold
33,402
– – ﹤0.01% 2338
2014
Q2 		$417K Buy
33,402
+9,575
+40% +$113K ﹤0.01% 2390
2014
Q1 		$266K Sell
23,827
-1,170
-5% -$12.8K ﹤0.01% 2607
2013
Q4 		$303K Hold
24,997
– – ﹤0.01% 2585
2013
Q3 		$305K Buy
24,997
+39
+0.2% +$544 ﹤0.01% 2513
2013
Q2 		$330K Buy
+24,958
New +$345K ﹤0.01% 2575

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return